Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (66.7%)
Phase 21 (33.3%)

Trials by Status

unknown125%
completed250%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
unknown

Prospective Registry for Patients With Chest Pain in Emergency Department

NCT05058300
completedphase_2

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

NCT01650441
terminatedphase_1

Computed Tomography (CT) in Head and Neck Patients

NCT00188656
completedphase_1

Dose Reduction in Thoracic CT

NCT00188461

Clinical Trials (4)

Showing 4 of 4 trials
NCT05058300

Prospective Registry for Patients With Chest Pain in Emergency Department

Unknown
NCT01650441Phase 2

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

Completed
NCT00188656Phase 1

Computed Tomography (CT) in Head and Neck Patients

Terminated
NCT00188461Phase 1

Dose Reduction in Thoracic CT

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4